Vivanza Biosciences P/B Ratio
Vivanza Biosciences (VIVANZA) P/B ratio is 1.77 (Moderate), book value per share ₹10.00 vs Healthcare average P/B of -0.18 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see Vivanza Biosciences share price chart.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
VIVANZA P/B Ratio — Valuation Insights & Book Value Analysis
Vivanza Biosciences price-to-book ratio interpretation, valuation status and historical context — current P/B 1.77 (Moderate). Check VIVANZA company valuation to track the company's total market size over time.
- Current PB is 238.2% above historical average
- Trading at premium to sector average PB of -0.18
Vivanza Biosciences P/B Ratio Historical Trend
VIVANZA annual price-to-book ratio — 3 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Also explore VIVANZA price trends to track price trends across different timeframes.
VIVANZA Historical P/B Ratio — Book Value Per Share & Year-End Price
Vivanza Biosciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.22 | ₹10.0 | ₹2.20 | ₹4 | Low |
| 2024 | 0.27 | ₹12.5 | ₹3.42 | ₹5 | Low |
| 2023 | 1.08 | ₹10.0 | ₹10.77 | ₹4 | Moderate |
VIVANZA vs Healthcare Peers — P/B Ratio Comparison
Vivanza Biosciences P/B 1.77 vs Healthcare average -0.18, median 0.67 — range -13.75–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -13.75 | ₹4,814 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |